Overview

Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants

Status:
Completed
Trial end date:
2017-02-27
Target enrollment:
Participant gender:
Summary
An oral dose in healthy subjects to obtain information about the absorption, metabolism, and excretion (AME) of BMS-986165
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Collaborator:
Covance
Treatments:
BMS-986165